GlassScriptPhysician profile
Wha-Joon Lee
NPI 1609870534
$2,539.62
in general payments reported to CMS, 2019-2025
21 companies · $451 in 2025
The $451 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $397 · 2021: $318 · 2022: $256 · 2023: $391 · 2024: $371 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $320.63 | 2019-2025 | Dupixent |
| Genzyme Corporation | $275.32 | 2022-2025 | |
| Alk-Abello, INC | $248.87 | 2019-2023 | Grastek, Odactra, Ragwitek |
| Acclarent, INC | $240.17 | 2019-2022 | |
| Inspire Medical Systems, INC. | $238.82 | 2023-2025 | Inspire |
| Stryker Corporation | $174.71 | 2019-2025 | Scopis Ent |
| Sanofi-Aventis U.S. LLC | $163.90 | 2019-2021 | |
| Aerin Medical INC. | $159.11 | 2020-2025 | |
| Glaxosmithkline, LLC. | $149.47 | 2021-2025 | Nucala |
| Optinose US, INC. | $113.97 | 2019-2024 | |
| Arrinex, INC. | $89.13 | 2019 | |
| Kaleo, INC. | $71.54 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $70.78 | 2020-2025 | Tezspire |
| Medtronic, INC. | $49.62 | 2024 | Propel, Ligasure |
| Merck Sharp & Dohme LLC | $40.37 | 2021-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $35.52 | 2022 | |
| Neurent Medical Limited | $26.27 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Axogen | $24.99 | 2025 | |
| Novartis Pharmaceuticals Corporation | $17.14 | 2019 | |
| Steris Corporation | $16.75 | 2023 | |
| Spirair, INC. | $12.54 | 2025 | Turbalign, Septalign |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wha-Joon Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.